Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Merck & Co., Inc.
Report date April 27, 2004 · Filed April 29, 2004
Section 16 reporting ended · disclosed 2004-04-29. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | IndirectBy Trust | 400 |
Reported balance
Holding disclosure · report date 2004-04-27 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 400 F1: The reporting person holds these shares in a retirement trust. |
| Common SharesSEC Table I · non-derivative | Direct | 15,341.1 |
Reported balance
Holding disclosure · report date 2004-04-27 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 15,341.1 F2: Includes 384.18 additional shares acquired under dividend reinvestment programs as of February 26, 2004. |
| Stock Equivalent UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 5,497.79 |
Reported balance
Holding disclosure · report date 2004-04-27 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 5,497.79 F3: 1 for 1 F4: Not Applicable. F5: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F6: Includes 16.83 shares acquired pursuant to a dividend reinvestment feature of the Directors Stock Equivalency Program, through February 26, 2004. |
| Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 2,568.84 |
Reported balance
Holding disclosure · report date 2004-04-27 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 2,568.84 F7: The stock units were credited pursuant to a deferral feature of the Directors Stock Award Plan. F8: Not Applicable. F9: The stock units will be paid in shares of stock on dates selected in accordance with the Plan. F10: Includes 68.84 shares acquired pursuant to a dividend reinvestment feature of the Issuer's Directors Stock Award Plan, through February 26, 2004. These stock units were credited pursuant to a deferral feature of the Plan and will be paid in shares of stock on dates selected in accordance with the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person holds these shares in a retirement trust.
F2: Includes 384.18 additional shares acquired under dividend reinvestment programs as of February 26, 2004.
F3: 1 for 1
F4: Not Applicable.
F5: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer.
F6: Includes 16.83 shares acquired pursuant to a dividend reinvestment feature of the Directors Stock Equivalency Program, through February 26, 2004.
F7: The stock units were credited pursuant to a deferral feature of the Directors Stock Award Plan.
F8: Not Applicable.
F9: The stock units will be paid in shares of stock on dates selected in accordance with the Plan.
F10: Includes 68.84 shares acquired pursuant to a dividend reinvestment feature of the Issuer's Directors Stock Award Plan, through February 26, 2004. These stock units were credited pursuant to a deferral feature of the Plan and will be paid in shares of stock on dates selected in accordance with the Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 01, 2004 Filed Jan 5, 2004 21:17 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 479.18 | $17.39 Strike: $0.00 | $8,332.94 |
DisclosureSEC source: 0000310158-04-000009 · mil315.xml · derivative · entry 1 MILLER DONALD L · CIK 0001238306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,480.96 Underlying: Common Shares · 479.18 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Stock Equivalency Program. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes 115.50 shares acquired pursuant to a dividend reinvestment feature of the Directors Stock Equivalency Program, through November 26, 2003. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.